Leflunomide has incremental cost advantage in RA

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 318, 2001 , pp. 7-7(1)

Keywords: Cost-minimisation; Infliximab, therapeutic use; Leflunomide, therapeutic use; Methotrexate, therapeutic use; Rheumatoid-arthritis, treatment

Language: English

Document Type: Research article

Links for this article

http://www.ingentaconnect.com/adis/peon/2001/00000001/00000318/art00027
http://openurl.ingenta.com/content?genre=article&issn=11735503&volume=1&issue=318&spage=7&epage=7